Skye Bioscience Inc.
skye bioscience (nasdaq: skye) is focused on unlocking the pharmaceutical potential of the endocannabinoid system, initially through modulation of the cb1 receptor, to treat diseases with inflammatory, fibrotic, and metabolic processes.
Last updated on
About Skye Bioscience Inc.
Founded
2012Employees
11-50Funding / Mkt. Cap
$111MCategory
Location
City
San DiegoState
CaliforniaCountry
United StatesSkye Bioscience Inc.
Find your buyer within Skye Bioscience Inc.
Tech Stack (24)
